These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12430204)

  • 1. [Multinational comparison of vascular complications in diabetes].
    Miki E
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():28-34. PubMed ID: 12430204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical characteristics of withdrawal from insulin therapy in NIDDM].
    Kanda T; Imano E; Iida M; Kawamori R
    Nihon Rinsho; 1997 Nov; 55 Suppl():727-32. PubMed ID: 9434555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intensive insulin therapy to prevent the progression of chronic vascular complications in type 2 diabetes mellitus].
    Kishikawa H; Araki E; Wake N; Shichiri M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():140-5. PubMed ID: 12386985
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of diabetic treatment on the development and progression of diabetic complications].
    Nakai T
    Nihon Rinsho; 1997 Nov; 55 Suppl():711-20. PubMed ID: 9434553
    [No Abstract]   [Full Text] [Related]  

  • 5. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy.
    Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475
    [No Abstract]   [Full Text] [Related]  

  • 6. How good is the statistical evidence against oral hypoglycemic agents?
    Feinstein AR
    Adv Intern Med; 1979; 24():71-95. PubMed ID: 371369
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early effect of therapy with pioglitazone. Vascular damage significantly reduced].
    MMW Fortschr Med; 2002 May; 144(21):53. PubMed ID: 12134428
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.
    Lebovitz HE
    J Indian Med Assoc; 2008 Nov; 106(11):724-6. PubMed ID: 19368098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Performance of real-world studies for inhaled insulin].
    Göke B
    Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S91-4. PubMed ID: 15988676
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.
    Lamanna C; Monami M; Marchionni N; Mannucci E
    Diabetes Obes Metab; 2011 Mar; 13(3):221-8. PubMed ID: 21205121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypoglycemic treatment of type 2 diabetes].
    Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"].
    MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes mellitus: is it possible to curb its prevalence and the incidence of late vascular complications?].
    Balabolkin MI
    Ter Arkh; 1993; 65(10):4-9. PubMed ID: 8296232
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current problems in the oral therapy of diabetes mellitus].
    Lubetzki J; Warnet A
    Therapie; 1979; 34(5):539-53. PubMed ID: 398082
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should prescription of oral hypoglycemies be continued? A social pharmacology problem. Experience of the diabetes outpatient clinic of the Sousse C.H.U].
    Bouraoui K; Douik E
    Tunis Med; 1981; 59(3):233-6. PubMed ID: 7256916
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
    Spesivtseva VG; Kasabian IN; Mamaeva GG; Kukes VG
    Sov Med; 1980; (2):64-9. PubMed ID: 6987747
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral hypoglycemic drugs: should they be used? Two views.
    Howard WJ; Savage PJ
    Ariz Med; 1978 Aug; 35(8):549-51. PubMed ID: 697600
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.